Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Farahmand, P., Marin, F., Hawkins, F., Moericke, R., Ringe, J. D., Glueer, C. -C., Papaioannou, N., Minisola, S., Martinez, G., Nolla, J. M., Niedhart, C., Guanabens, N., Nuti, R., Martin-Mola, E., Thomasius, F., Pena, J., Graeff, C., Kapetanos, G., Petto, H., Gentzel, A., Reisinger, A. and Zysset, P. K. (2013). Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporosis Int., 24 (12). S. 2971 - 2982. LONDON: SPRINGER LONDON LTD. ISSN 1433-2965

Ringe, J. D. and Farahmand, P. (2017). EPIDEMIOLOGY OF VITAMIN D SUPPLY IN GERMANY: ASSESSMENT ON 1343 UNSELECTED PATIENTS. Osteoporosis Int., 28. S. S129 - 1. LONDON: SPRINGER LONDON LTD. ISSN 1433-2965

Ringe, J. D. and Farahmand, P. (2014). EXCELLENT ADHERENCE TO 6-MONTHLY DENOSUMAB INJECTIONS DUE TO POSITIVE FEEDBACK BASED ON 6 AND 12 MONTHS BMD INCREASES AND RARE ADVERSE EVENTS IN PATIENTS WITH DIFFERENT FORMS OF OSTEOPOROSIS. Osteoporosis Int., 25. S. S217 - 2. LONDON: SPRINGER LONDON LTD. ISSN 1433-2965

Ringe, J. D. and Farahmand, P. (2018). IN PATIENTS WITH DIFFERENT FORMS OF OSTEOPOROSIS EXCELLENT ADHERENCE TO 6-MONTHLY DENOSUMAB INJECTIONS CAN BE ACHIEVED BY POSITIVE FEEDBACK BASED ON 6 AND 12 MONTHS BMD INCREASES AND RARE ADVERSE EVEN. Osteoporosis Int., 29. S. S238 - 1. LONDON: SPRINGER LONDON LTD. ISSN 1433-2965

Ringe, J. D. and Farahmand, P. (2014). Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile. Rheumatol. Int., 34 (5). S. 727 - 733. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1437-160X

This list was generated on Sun May 19 05:11:43 2024 CEST.